Camlin Fine Sciences Rights Issue 2025 Offer Details
Camlin Fine Sciences Rights Issue Date: | 17 to 27 January 2025 |
Rights Issue Size (in INR): | Approx ₹7.93 Crores |
Rights Issue Size (in Shares): | 79,25,339 Equity Share |
Issue Price: | ₹110 Per Equity Share |
Face Value: | ₹1 Per Equity Share |
Listing on: | BSE NSE |
BSE Code: | 42446 |
NSE Code: | Book Built Issue |
Issue Entitlement Ratio: | 5:41 (5 rights share for every 41 shares held on record date) |
Payment Terms | Fully payable at the time of application |
Employee Discount: | ₹[.] per share |
Camlin Fine Sciences Rights Issue 2025 Offer Documents
Letter of Offer: | Click Here |
Application Form: | Click Here |
Live Share Price | Click Here |
Camlin Fine Sciences Rights Issue 2025 Dates | Time Table
Last Date to buy shares: | 7 January 2025 |
Rights Issue Record Date: | 8 January 2025 |
Credit of Rights Entitlements: | 2025 |
Issue Offer Opens On: | 17 January 2025 |
Renunciation of Rights Entitlements: | 23 January 2025 |
Issue Offer Closes On: | 27 January 2025 |
Basis of Allotment Date: | 2025 |
Credit Date: | 2025 |
Listing Date: | 2025 |
Camlin Fine Sciences Rights Issue Calculation
Rights Issue Price: | ₹110 per share |
Market Price on Rights Issue Approval: | ₹138.40 per share |
Dilution Factor (X): | 1.12 |
Fair Value After Dilution at Prevailing Price: | ₹135.31 per share |
How to Apply for Camlin Fine Sciences Rights Issue
- Net Banking (ASBA Method)
- Registrar’s Website (R-WAP)
About Camlin Fine Sciences
Camlin Fine Science Limited was incorporated in 1931 and provides high-quality solutions to extend shelf life including antioxidants, aroma ingredients, and performance chemicals. They have been on a long journey from an ink and color company to a fine sciences firm while keeping their original culture of innovation, focus on technology development and passion for improving the entire value chain. They have strengthened their manufacturing by combining all stages such as combining knowledge, technical expertise, and a passion for innovation. In 2006, to bring greater focus to its main purpose, this new division was demerged from the parent company and an entirely new entity was formed called ‘Camlin Fine Sciences Ltd.’
Objects of the Rights Issue
- Repayment or prepayment, in full or in part, of certain borrowings availed by the company
- General corporate purposes
Camlin Fine Sciences Company Financial Report
₹ in Crores
Period Ended | Revenue | Expense | Profit After Tax |
2022 | ₹704.21 | ₹668.14 | ₹25.87 |
2023 | ₹818.27 | ₹751.64 | ₹47.55 |
2024 | ₹792.14 | ₹849.85 | ₹51.39 |
Camlin Fine Sciences Rights Issue Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Phone: +91 810 811 4949
Email: camlin.rightsissue@linkintime.co.in
Website: www.linkintime.co.in
Camlin Fine Sciences Rights Issue Lead Manager
- Centrum Capital Limited
Camlin Fine Sciences Rights Issue allotment status check on Link Intime India Private Limited
website – Click Here
Promoters of Camlin Fine Sciences
- Ashish Dandekar
- Anagha Dandekar
- Camart Finance Limited
- Vibha Agencies Private Limited
- Cafco Consultants Limited
- MK Falcon Agro Tech Private Limited
- Infinity Holdings
- Infinity Direct Holdings
- Infinity Direct Holdings Sidecar I
- Infinity Portfolio Holdings
- Anfima NV
Company Address
Camlin Fine Sciences Ltd.
Floor 2to 5, Building in GS. Point, Plot No. VIII
Private Layout Scheme, Opp. University Campus,
C.S.T. Road, Kalina, Santa-Mumbai-400098
Phone: 02267001000
Email: secretarial@camlinfs.com
Website: http://www.camlinfs.com/